Testosterone Palmitate Lipid Delivery System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmaceutical delivery systems for hydrophobic drugs, such as testosterone, face challenges in achieving enhanced and extended bioavailability, particularly when administered orally, due to poor water solubility and extensive first-pass hepatic metabolism.
Innovation Solution
A pharmaceutical composition comprising testosterone palmitate (TP) or a testosterone ester, combined with two or more lipid components, including a hydrophilic surfactant and a lipophilic surfactant, which provides controlled release and solubilization of TP, enhancing its absorption and pharmacokinetics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If testosterone is administered orally, then complete absorption into portal circulation is achieved, but extensive first-pass hepatic metabolism results in low serum concentration
Solution Approach 1:
The patent uses lipid-based delivery systems (micelles, liposomes, or lipid emulsions) as intermediary carriers to transport testosterone through the portal circulation to bypass hepatic metabolism. The lipid carrier protects the drug from first-pass metabolism and enables direct entry into systemic circulation, resolving the contradiction between complete absorption and low serum concentration caused by hepatic metabolism.
Solution Approach 2:
The patent alters the physical-chemical parameters of testosterone by forming complexes with lipids or converting to testosterone esters. This parameter change modifies the drug's pharmacokinetic profile, reducing hepatic extraction and extending circulation time, thereby maintaining reliable serum concentrations despite oral administration.
2Reliability
If testosterone esters are used to reduce hepatic metabolism, then bioavailability is improved, but hepatotoxicity occurs with alkylated derivatives
Solution Approach 1:
The patent employs lipid carriers as intermediaries to deliver testosterone esters, avoiding direct contact with hepatic enzymes that cause toxicity. The lipid matrix controls the release rate and protects the liver from direct exposure to high concentrations of potentially toxic esters, maintaining bioavailability while reducing hepatotoxicity.
Solution Approach 2:
The patent modifies the molecular structure by selecting specific testosterone esters with appropriate chain lengths and degrees of unsaturation. These parameter changes optimize the balance between bioavailability and hepatotoxicity, choosing esters that provide sustained release without excessive liver stress.
3Reliability
If lipophilic solvents and surfactants are used to enhance transient bioavailability, then absorption is improved, but serum concentrations cannot be maintained over extended period
Solution Approach 1:
The patent creates dynamic lipid delivery systems that can adapt their structure and release rate in response to physiological conditions. The lipid carriers undergo phase transitions or structural reorganization in vivo, enabling initial rapid release for enhanced bioavailability followed by sustained release to maintain serum concentrations over extended periods.
Solution Approach 2:
The patent uses composite lipid formulations combining multiple lipid components with different release characteristics. This composite approach allows the system to provide both rapid initial release (enhancing transient bioavailability) and sustained release (maintaining serum concentrations), resolving the contradiction between short-term absorption improvement and long-term concentration maintenance.
4Duration of action of moving object
If multiple lipid components are combined for controlled release, then extended serum concentrations are achieved, but formulation complexity increases
Solution Approach 1:
The patent divides the lipid delivery system into distinct functional segments, each with a specific role (e.g., core lipid for solubility, shell lipid for controlled release, surfactant for stability). This segmentation allows for systematic optimization of each component while maintaining overall formulation manageability and achieving extended serum concentrations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described composition achieves enhanced bioavailability and extended serum concentrations of testosterone, providing effective relief from testosterone deficiency symptoms with reduced dosing frequency and improved patient convenience.
Implementation Method 1
two or more lipid components at least the first of which comprises a hydrophilic surfactant and at least the second of which comprises a lipophilic surfactant that provides for the controlled release of TP, said lipid components together providing for the solubilization of TP
Data Source
AI summary
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.